Owners, management and financials
CVR: 21023884
Previous names: GFKJUS 519 ApS
USD 3,720,000,000
Revenue
Net result: USD 963,000,000
BLACKROCK, INC. (5-9,99%), Darwin Global Management Limited (0%)
CVR · view owners
Jan van de Winkel, Anthony Michael Pagano
Board: Deirdre Patrice Connelly (chair) and 10 members
CVR · view management
Active
Founded 11 June 1998
CVR · view overview
698 employees
CVR · 2026
Owner registered: Darwin Global Management Limited
CVR · 28/09/2026
View the full event history
GENMAB A/S is a Danish company of the type Aktieselskab based in Valby, founded in 1998. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named GFKJUS 519 ApS. The management consists of Jan van de Winkel and Anthony Michael Pagano. The board consists of Deirdre Patrice Connelly (chair), Pernille Lyngvold Erenbjerg, Anders Gersel Pedersen and Elizabeth Grimes O’Farrell. The company is owned by BLACKROCK, INC. and Darwin Global Management Limited. The company has 698 employees (2026). In 2025, the company reported revenue of USD 3,720,000,000 and a net result of USD 963,000,000 compared with DKK 7,844,000,000 the year before. Equity in the 2025 report amounted to USD 5,847,000,000.
Source: annual report 2025, Danish Business Authority
GENMAB A/S exhibits strong financial health, highlighted by a significant profit of 963 million USD in 2025 and a robust equity position of approximately 5.85 billion USD. Revenue has shown a consistent upward trajectory, increasing from 14.6 billion DKK in 2022 to 21.5 billion DKK in 2024, with a notable shift to USD reporting in 2025. The interim results for the first half of 2026 indicate a revenue of 2.05 billion USD and a profit of 356 million USD, suggesting that the company is on track to potentially exceed its previous full-year results. With a solid equity base and a growing profit trend, GENMAB is well-positioned within the life sciences industry, although the lack of gross profit data raises some concerns regarding margin transparency.
AI-generated summary · Generated 14/08/2026
Selskabets formål er at udøve medicinsk forskning, produktion og salg af sådanne produkter samt anden dermed i forbindelse stående virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 3.7B USD | 963M USD | 12.9B USD | 5.8B USD | 2694 | |
| 202401/01/2024 – 31/12/2024 | 21.5B | 7.8B | 45.8B | 36.7B | 2011 | |
| 202301/01/2023 – 31/12/2023 | 16.5B | 4.4B | 35.3B | 31.6B | 2011 | |
| 202201/01/2022 – 31/12/2022 | 14.6B | 5.5B | 30.3B | 27.4B | 313 | |
| 202101/01/2021 – 31/12/2021 | 8.5B | 3B | 24.6B | 22.2B | 235 | |
| 202001/01/2020 – 31/12/2020 | 10.1B | 4.8B | 21.1B | 19.1B | - | |
| 201901/01/2019 – 31/12/2019 | 5.4B | 2.2B | 15.1B | 14B | - | |
| 201801/01/2018 – 31/12/2018 | 3B | 1.5B | 8.5B | 8B | - | |
| 201701/01/2017 – 31/12/2017 | 2.4B | 1.1B | 6.6B | 6.3B | - | |
| 201601/01/2016 – 31/12/2016 | 1.8B | 1.2B | 5.2B | 4.8B | - | |
| 201501/01/2015 – 31/12/2015 | 1.1B | 763.5M | 3.9B | 3.5B | - | |
| 201401/01/2014 – 31/12/2014 | 850.4M | 301.3M | 2.9B | 2B | - |
Daily closing prices, Nasdaq Copenhagen
Compared to 1.037 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of GENMAB A/S is 21023884.
GENMAB A/S is owned by BLACKROCK, INC. and Darwin Global Management Limited.
The management of GENMAB A/S consists of Jan van de Winkel and Anthony Michael Pagano.
The board of GENMAB A/S consists of Deirdre Patrice Connelly, Pernille Lyngvold Erenbjerg and Anders Gersel Pedersen, with Deirdre Patrice Connelly as chair.
In 2025, GENMAB A/S reported revenue of USD 3,720,000,000.
GENMAB A/S had 698 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
As of September 28, 2026, is registered as an owner of GENMAB A/S.
As of August 15, 2026, Gina Theresa Schweizer has joined the board of directors of GENMAB A/S.
As of August 14, 2026, Michael Arthur Kavanagh has left the board of directors of GENMAB A/S.
As of August 14, 2026, Gina Theresa Schweizer has left the board of directors of GENMAB A/S.
GENMAB A/S has published its interim report for the period January 1, 2026 to June 30, 2026.
GENMAB A/S has published its interim report for the period January 1, 2026 to March 31, 2026.
GENMAB A/S has published its annual report for 2025. Revenue came to DKK 3,720,000,000, and the net result was DKK 963,000,000.
GENMAB A/S has published its interim report for the period January 1, 2025 to September 30, 2025.
GENMAB A/S has published its interim report for the period January 1, 2025 to June 30, 2025.
GENMAB A/S has published its interim report for the period January 1, 2025 to March 31, 2025.
GENMAB A/S has published its annual report for 2024. Revenue came to DKK 21,526,000,000, and the net result was DKK 7,844,000,000.
As of March 12, 2025, Martha Theresa Ramirez-Andersen has joined the board of directors of GENMAB A/S.
As of March 12, 2025, Michael Arthur Kavanagh has joined the board of directors of GENMAB A/S.
As of March 12, 2025, Gina Theresa Schweizer has joined the board of directors of GENMAB A/S.
As of March 12, 2025, Ogi Takahashi has joined the board of directors of GENMAB A/S.
As of March 12, 2025, Julie Blædel has left the board of directors of GENMAB A/S.
As of March 12, 2025, Takahiro Hamatani has left the board of directors of GENMAB A/S.
As of March 12, 2025, Richard Gordon Hibbert has left the board of directors of GENMAB A/S.
GENMAB A/S has published its interim report for the period January 1, 2024 to September 30, 2024.
GENMAB A/S has published its interim report for the period January 1, 2024 to June 30, 2024.
GENMAB A/S has published its interim report for the period April 1, 2024 to June 30, 2024.
GENMAB A/S has published its interim report for the period January 1, 2024 to March 31, 2024.
GENMAB A/S has published its annual report for 2023. Revenue came to DKK 16,474,000,000, and the net result was DKK 4,352,000,000.
As of March 13, 2024, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of GENMAB A/S.
As of March 13, 2024, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of GENMAB A/S.
As of March 13, 2024, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of GENMAB A/S.
GENMAB A/S has published its interim report for the period January 7, 2023 to September 30, 2023.
GENMAB A/S has published its interim report for the period January 1, 2023 to June 30, 2023.
GENMAB A/S has published its interim report for the period January 1, 2023 to March 31, 2023.
As of April 10, 2023, Suzana Sturlini Couto has left the board of directors of GENMAB A/S.
GENMAB A/S has published its annual report for 2022. Revenue came to DKK 14,595,000,000, and the net result was DKK 5,522,000,000.
As of January 1, 2023, Judith Viviana Klimovsky has stepped down as director of GENMAB A/S.
As of January 1, 2023, Anthony Mancini has stepped down as director of GENMAB A/S.
As of January 1, 2023, Tahamtan Ahmadi has stepped down as director of GENMAB A/S.
GENMAB A/S has published its interim report for the period January 1, 2022 to September 30, 2022.
GENMAB A/S has published its interim report for the period January 1, 2022 to June 30, 2022.
GENMAB A/S has published its interim report for the period January 1, 2022 to March 31, 2022.
GENMAB A/S has published its annual report for 2021. Revenue came to DKK 8,482,000,000, and the net result was DKK 3,008,000,000.
As of March 29, 2022, Julie Blædel has joined the board of directors of GENMAB A/S.
As of March 29, 2022, Martin Schultz has joined the board of directors of GENMAB A/S.
As of March 29, 2022, Takahiro Hamatani has joined the board of directors of GENMAB A/S.
As of March 29, 2022, Elizabeth Grimes O’Farrell has joined the board of directors of GENMAB A/S.
As of March 29, 2022, Richard Gordon Hibbert has joined the board of directors of GENMAB A/S.
As of March 29, 2022, Suzana Sturlini Couto has joined the board of directors of GENMAB A/S.
As of March 29, 2022, Peter Storm Kristensen has left the board of directors of GENMAB A/S.
As of March 29, 2022, Nina Holst has left the board of directors of GENMAB A/S.
As of March 29, 2022, Simone de Haij has left the board of directors of GENMAB A/S.
As of March 29, 2022, Rima Bawarshi Nassar has left the board of directors of GENMAB A/S.
GENMAB A/S has published its interim report for the period January 1, 2021 to September 30, 2021.
As of November 15, 2021, Jonathan Michael Peacock has left the board of directors of GENMAB A/S.
GENMAB A/S has published its interim report for the period January 1, 2021 to June 30, 2021.
GENMAB A/S has published its annual report for 2020. Revenue came to DKK 10,111,000,000, and the net result was DKK 4,758,000,000.
As of March 1, 2021, Tahamtan Ahmadi is registered as director of GENMAB A/S.
GENMAB A/S has published its interim report for the period January 1, 2020 to September 30, 2020.
GENMAB A/S has published its interim report for the period January 1, 2020 to June 30, 2020.
As of August 17, 2020, Rima Bawarshi Nassar has joined the board of directors of GENMAB A/S.
As of August 17, 2020, Daniel John Bruno has left the board of directors of GENMAB A/S.
As of August 16, 2020, Rima Bawarshi Nassar has left the board of directors of GENMAB A/S.
GENMAB A/S has published its interim report for the period January 1, 2020 to March 31, 2020.
GENMAB A/S has published its annual report for 2019. Revenue came to DKK 5,366,000,000, and the net result was DKK 2,166,000,000.
As of March 26, 2020, Pernille Lyngvold Erenbjerg has joined the board of directors of GENMAB A/S.
As of March 26, 2020, Deirdre Patrice Connelly has joined the board of directors of GENMAB A/S.
As of March 26, 2020, Jonathan Michael Peacock has joined the board of directors of GENMAB A/S.
As of March 26, 2020, Mats Gunnar Pettersson has left the board of directors of GENMAB A/S.
As of March 25, 2020, Pernille Lyngvold Erenbjerg has left the board of directors of GENMAB A/S.
As of March 25, 2020, Deirdre Patrice Connelly has left the board of directors of GENMAB A/S.
As of March 23, 2020, Anthony Mancini is registered as director of GENMAB A/S.
As of March 1, 2020, Anthony Michael Pagano is registered as director of GENMAB A/S.
As of March 1, 2020, David Andrew Eatwell has stepped down as økonomidirektør of GENMAB A/S.
GENMAB A/S has published its interim report for the period January 1, 2019 to September 30, 2019.
GENMAB A/S has published its interim report for the period January 1, 2019 to June 30, 2019.
As of July 18, 2019, is registered as an owner of GENMAB A/S with an ownership share of 5%.
GENMAB A/S has published its interim report for the period January 1, 2019 to March 31, 2019.
GENMAB A/S has published its annual report for 2018. Revenue came to DKK 3,025,137,000, and the net result was DKK 1,472,141,000.
As of March 22, 2019, Nina Holst has joined the board of directors of GENMAB A/S.
As of March 22, 2019, Mijke Zachariasse has joined the board of directors of GENMAB A/S.
As of March 22, 2019, Simone de Haij has joined the board of directors of GENMAB A/S.
As of March 22, 2019, Rima Bawarshi Nassar has joined the board of directors of GENMAB A/S.
As of March 22, 2019, Richard Gordon Hibbert has left the board of directors of GENMAB A/S.
As of March 22, 2019, Stephen Paul Bryant has left the board of directors of GENMAB A/S.
GENMAB A/S has published its interim report for the period January 1, 2018 to September 30, 2018.
GENMAB A/S has published its interim report for the period January 1, 2018 to June 30, 2018.
GENMAB A/S has published its interim report for the period January 1, 2018 to March 31, 2018.
GENMAB A/S has published its annual report for 2017. Revenue came to DKK 2,365,436,000, and the net result was DKK 1,103,551,000.
As of April 10, 2018, Anders Gersel Pedersen has joined the board of directors of GENMAB A/S.
As of April 10, 2018, Deirdre Patrice Connelly has joined the board of directors of GENMAB A/S.
As of April 9, 2018, Anders Gersel Pedersen has left the board of directors of GENMAB A/S.
As of April 9, 2018, Deirdre Patrice Connelly has left the board of directors of GENMAB A/S.
GENMAB A/S has published its interim report for the period January 1, 2017 to September 30, 2017.
As of October 31, 2017, Pernille Kristine Hemmingsen has left the board of directors of GENMAB A/S.
GENMAB A/S has published its interim report for the period January 1, 2017 to June 30, 2017.
GENMAB A/S has published its interim report for the period January 1, 2017 to March 31, 2017.
As of March 31, 2017, Tom Vink has left the board of directors of GENMAB A/S.
GENMAB A/S has published its annual report for 2016. Revenue came to DKK 1,816,122,000, and the net result was DKK 1,187,075,000.
As of March 28, 2017, Deirdre Patrice Connelly has joined the board of directors of GENMAB A/S.
As of March 28, 2017, Rolf Karl Heinz Hoffmann has joined the board of directors of GENMAB A/S.
As of March 28, 2017, Burton Gordon Malkiel has left the board of directors of GENMAB A/S.
As of February 13, 2017, Judith Viviana Klimovsky is registered as director of GENMAB A/S.
GENMAB A/S has published its interim report for the period January 1, 2016 to June 30, 2016.
GENMAB A/S has published its interim report for the period January 1, 2016 to March 31, 2016.
GENMAB A/S has published its annual report for 2015. Revenue came to DKK 1,133,041,000, and the net result was DKK 763,513,000.
As of March 17, 2016, Pernille Kristine Hemmingsen has joined the board of directors of GENMAB A/S.
As of March 17, 2016, Peter Storm Kristensen has joined the board of directors of GENMAB A/S.
As of March 17, 2016, Tom Vink has joined the board of directors of GENMAB A/S.
As of March 17, 2016, Richard Gordon Hibbert has joined the board of directors of GENMAB A/S.
As of March 17, 2016, Daniel John Bruno has joined the board of directors of GENMAB A/S.
As of March 17, 2016, Stephen Paul Bryant has joined the board of directors of GENMAB A/S.
As of March 17, 2016, Nedjad Losic has left the board of directors of GENMAB A/S.
As of March 17, 2016, Barbara Brouwer has left the board of directors of GENMAB A/S.
As of March 16, 2016, Tom Vink has left the board of directors of GENMAB A/S.
GENMAB A/S has published its interim report for the period January 1, 2015 to September 30, 2015.
GENMAB A/S has published its interim report for the period January 1, 2015 to June 30, 2015.
GENMAB A/S has published its interim report for the period January 1, 2015 to March 31, 2015.
GENMAB A/S has published its annual report for 2014. Revenue came to DKK 850,385,000, and the net result was DKK 301,296,000.
As of March 26, 2015, Pernille Lyngvold Erenbjerg has joined the board of directors of GENMAB A/S.
As of March 26, 2015, Paolo Augusto Paoletti has joined the board of directors of GENMAB A/S.
As of March 26, 2015, Hans Henrik Munch-Jensen has left the board of directors of GENMAB A/S.
GENMAB A/S has published its interim report for the period July 1, 2014 to September 30, 2014.
As of September 30, 2014, Anders Boelskift has left the board of directors of GENMAB A/S.
GENMAB A/S has published its interim report for the period January 1, 2014 to June 30, 2014.
GENMAB A/S has published its interim report for the period January 1, 2014 to March 31, 2014.
GENMAB A/S has published its annual report for 2013.
GENMAB A/S has published its interim report for the period July 1, 2013 to September 30, 2013.
GENMAB A/S has published its interim report for the period January 1, 2013 to June 30, 2013.
GENMAB A/S has published its interim report for the period January 1, 2013 to March 31, 2013.
GENMAB A/S has published its annual report for 2012.
As of April 17, 2013, Anders Boelskift has joined the board of directors of GENMAB A/S.
As of April 17, 2013, Anders Gersel Pedersen has joined the board of directors of GENMAB A/S.
As of April 17, 2013, Anders Gersel Pedersen has joined the board of directors of GENMAB A/S.
As of April 17, 2013, Burton Gordon Malkiel has joined the board of directors of GENMAB A/S.
As of April 17, 2013, Mats Gunnar Pettersson has joined the board of directors of GENMAB A/S.
As of April 17, 2013, Barbara Brouwer has joined the board of directors of GENMAB A/S.
As of April 17, 2013, Karsten Havkrog Pedersen has left the board of directors of GENMAB A/S.
As of April 17, 2013, Thomas Oettinger has left the board of directors of GENMAB A/S.
As of April 17, 2013, Anders Gersel Pedersen has left the board of directors of GENMAB A/S.
As of April 17, 2013, Stephen Paul Bryant has left the board of directors of GENMAB A/S.
As of April 17, 2013, Peter Hendrik Ros has left the board of directors of GENMAB A/S.
As of April 17, 2013, Daniel John Bruno has left the board of directors of GENMAB A/S.
As of April 17, 2013, Michael Blair Widmer has left the board of directors of GENMAB A/S.
As of April 17, 2013, Burton Gordon Malkiel has left the board of directors of GENMAB A/S.
As of April 17, 2013, Antonius Theodorus Maria Wilderbeek has left the board of directors of GENMAB A/S.
As of April 25, 2012, Michael Blair Widmer has joined the board of directors of GENMAB A/S.
As of April 25, 2012, Burton Gordon Malkiel has joined the board of directors of GENMAB A/S.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of GENMAB A/S.
As of July 1, 2011, A/S PSE NR. 4820 has stepped down as auditor of GENMAB A/S.
As of April 6, 2011, Antonius Theodorus Maria Wilderbeek has joined the board of directors of GENMAB A/S.
As of June 15, 2010, Lisa Natale Drakeman has left the board of directors of GENMAB A/S.
As of June 15, 2010, Jan van de Winkel is registered as adm. dir. of GENMAB A/S.
As of June 15, 2010, Lisa Natale Drakeman has stepped down as director of GENMAB A/S.
As of June 2, 2010, Nedjad Losic has joined the board of directors of GENMAB A/S.
As of June 2, 2010, Thomas Oettinger has joined the board of directors of GENMAB A/S.
As of June 2, 2010, Stephen Paul Bryant has joined the board of directors of GENMAB A/S.
As of June 2, 2010, Peter Hendrik Ros has joined the board of directors of GENMAB A/S.
As of June 2, 2010, Daniel John Bruno has joined the board of directors of GENMAB A/S.
As of June 2, 2010, Tom Vink has joined the board of directors of GENMAB A/S.
As of April 15, 2009, Ernst Jakob Schweizer has left the board of directors of GENMAB A/S.
As of September 3, 2008, Claus Juan Møller-San Pedro has stepped down as director of GENMAB A/S.
As of June 2, 2008, David Andrew Eatwell is registered as økonomidirektør of GENMAB A/S.
As of June 2, 2008, Bo Kruse has stepped down as director of GENMAB A/S.
As of April 19, 2007, Hans Henrik Munch-Jensen has joined the board of directors of GENMAB A/S.
As of January 31, 2007, Irwin Lerner has left the board of directors of GENMAB A/S.
As of September 21, 2005, Bo Kruse is registered as director of GENMAB A/S.
As of August 5, 2005, Alberto Elli has stepped down as director of GENMAB A/S.
As of June 6, 2005, Alberto Elli is registered as director of GENMAB A/S.
As of April 20, 2005, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of GENMAB A/S.
As of August 1, 2003, Michael Wolff Jensen has stepped down as director of GENMAB A/S.
As of April 24, 2003, Jesper Zeuthen has left the board of directors of GENMAB A/S.
As of March 7, 2002, Karsten Havkrog Pedersen has joined the board of directors of GENMAB A/S.
As of March 7, 2002, Leif Helth Jensen has left the board of directors of GENMAB A/S.
As of March 7, 2002, Francesco de Rubertis has left the board of directors of GENMAB A/S.
As of January 21, 2002, Zahad Subhan has stepped down as director of GENMAB A/S.
As of October 1, 2001, Zahad Subhan is registered as director of GENMAB A/S.
As of April 19, 2001, A/S PSE NR. 4820 has been appointed auditor of GENMAB A/S.
As of March 22, 2001, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of GENMAB A/S.
As of March 22, 2001, A/S PSE NR. 2857 has stepped down as auditor of GENMAB A/S.
As of March 22, 2001, A/S PSE NR. 4820 has stepped down as auditor of GENMAB A/S.
As of March 22, 2001, Francesco de Rubertis has joined the board of directors of GENMAB A/S.
As of March 22, 2001, Neil Rimer has left the board of directors of GENMAB A/S.
As of August 25, 2000, A/S PSE NR. 2857 has been appointed auditor of GENMAB A/S.
As of July 27, 2000, Irwin Lerner has joined the board of directors of GENMAB A/S.
As of July 27, 2000, Dwight Kinsey has left the board of directors of GENMAB A/S.
As of July 27, 2000, Michael Wolff Jensen is registered as director of GENMAB A/S.
As of July 25, 2000, A/S PSE NR. 4820 has been appointed auditor of GENMAB A/S.
As of July 25, 2000, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of GENMAB A/S.
As of July 21, 2000, Neil Rimer has joined the board of directors of GENMAB A/S.
As of July 21, 2000, Dwight Kinsey has joined the board of directors of GENMAB A/S.
As of February 2, 2000, Leif Helth Jensen has joined the board of directors of GENMAB A/S.
As of December 22, 1999, Eva Steiness has left the board of directors of GENMAB A/S.
As of February 25, 1999, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of GENMAB A/S.
As of February 25, 1999, EY Danmark A/S has stepped down as auditor of GENMAB A/S.
As of February 25, 1999, Jesper Zeuthen has joined the board of directors of GENMAB A/S.
As of February 25, 1999, Lisa Natale Drakeman has joined the board of directors of GENMAB A/S.
As of February 25, 1999, Ernst Jakob Schweizer has joined the board of directors of GENMAB A/S.
As of February 25, 1999, Claus Juan Møller-San Pedro is registered as director of GENMAB A/S.
As of February 25, 1999, Lisa Natale Drakeman is registered as director of GENMAB A/S.
As of February 15, 1999, Eva Steiness has joined the board of directors of GENMAB A/S.
On November 18, 1998, the company changed its name from GFKJUS 519 ApS to GENMAB A/S.
As of November 17, 1998, EY Danmark A/S has been appointed auditor of GENMAB A/S.
As of November 17, 1998, Pricewaterhouse Coopers has stepped down as auditor of GENMAB A/S.
As of November 17, 1998, Klaus Søgaard has left the board of directors of GENMAB A/S.
As of November 17, 1998, Jan-Erik Gunnar Svensson has left the board of directors of GENMAB A/S.
As of November 17, 1998, Troels Elkiær Andersen has left the board of directors of GENMAB A/S.
As of November 17, 1998, Klaus Søgaard has stepped down as director of GENMAB A/S.
As of June 11, 1998, Pricewaterhouse Coopers has been appointed auditor of GENMAB A/S.
As of June 11, 1998, Klaus Søgaard has joined the board of directors of GENMAB A/S.
As of June 11, 1998, Jan-Erik Gunnar Svensson has joined the board of directors of GENMAB A/S.
As of June 11, 1998, Troels Elkiær Andersen has joined the board of directors of GENMAB A/S.
As of June 11, 1998, Klaus Søgaard is registered as director of GENMAB A/S.
GENMAB A/S was founded on June 11, 1998.
37 news items and press releases
Sources: Via Ritzau and Danish news media. Links open at the source.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 46133684
CVR 46429931
CVR 40596585
CVR 45599124
CVR 33910126
